Plasma p-tau markers and vascular factors are associated with cognitive decline and clinical progression in the CIMA-Q cohort
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction
We compared associations between phosphorylated tau biomarkers (p-tau217, p-tau181, p-tau231) and vascular risk factors with clinical progression and cognitive decline along the AD continuum.
Methods
Baseline plasma p-tau concentrations and vascular risk factors were assessed in 280 CIMA-Q participants. Associations between these markers, cognition and clinical progression over 8 years were examined.
Results
Elevated p-tau217 predicted progression from mild cognitive impairment (MCI) to AD dementia ( p <.01), while hypertension predicted progression from cognitively unimpaired (CU) to MCI ( p <.02). Higher p-tau levels, particularly p-tau217, and hypertension were linked to cognitive decline in MCI individuals. In the CU group, few associations were seen between p-tau levels and cognitive decline, with minimal effect of vascular risk factors.
Discussion
Plasma p-tau217 was the most sensitive marker of AD-related decline, but hypertension was particularly relevant at earlier stages. The results highlight the need for multimodal profiling to optimize prediction and intervention along the AD continuum.
